Akizawa Tadao

アキザワタダオ | Akizawa Tadao

Affiliation and department：
Job title： Professor

Research field (1)： Nephrology

Research keywords (6)：代謝性骨疾患 , 血液浄化医学 , 腎臓内科学 , Metabolic Bone Disease , Blood Purification , Nephrology

Research theme for competitive and other funds (17)：

2008 - 2010 Experimental study for the regression of chronic kidney disease and mineral bone disorder(CKD-MBD)
2006 - 2007 Cross talk between the onset of renal osteodystrophy and ectopic vascular calcification
2004 - 2005 Effect of renal hyperparathyroidism on the vascular calcification in uremic rats.
2003 - 2004 THE ANALYSIS OF ADENOVO GENE IS EXPRESSED WITH SECONDARY HYPERPARATHYROIDISM
2002 - 2003 Pathogenesis and control of renal osteodystrophy

Show all

Papers (605)：

Masanori Kato, Hidetoshi Ito, Akane Yamakawa, Tatsuo Kagimura, Masafumi Fukagawa, Masahiro Yamamoto, Yoshinori Saito, Tadao Akizawa, Hiroaki Ogata. Effect of aspirin on cardiovascular events in patients undergoing hemodialysis with hyperphosphatemia: A post hoc analysis of the LANDMARK trial. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2024. 28. 4. 580-590
Masaaki Nakayama, Shuhei Kobayashi, Miho Kusakabe, Meiko Ohara, Kaoru Nakanishi, Tadao Akizawa, Masafumi Fukagawa. Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial. Clinical and experimental nephrology. 2023
Masanori Tokumoto, Shin Tokunaga, Shinji Asada, Yuichi Endo, Noriaki Kurita, Masafumi Fukagawa, Tadao Akizawa. Predictive factors requiring high-dose evocalcet in hemodialysis patients with secondary hyperparathyroidism. PLOS ONE. 2022. 17. 12. e0279078-e0279078
Kiryu Yoshida, Takuya Mizukami, Masafumi Fukagawa, Tadao Akizawa, Hokuto Morohoshi, Takehiko Sambe, Akiko Takeshima, Hidetoshi Ito, Hiroaki Ogata, Naoki Uchida. Effect of vitamin D receptor activators on cardiovascular events in patients on hemodialysis-A post hoc analysis of the LANDMARK study. Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy. 2022
Kiryu Yoshida, Takuya Mizukami, Masafumi Fukagawa, Tadao Akizawa, Hokuto Morohoshi, Takehiko Sambe, Hidetoshi Ito, Hiroaki Ogata, Naoki Uchida. Target phosphate and calcium levels in patients undergoing hemodialysis: a post-hoc analysis of the LANDMARK study. Clinical and experimental nephrology. 2022

ｍore...

MISC (210)：

峰島三千男, 友雅司, 中元秀友, 宍戸寛治, 秋澤忠男, 内野順司, 本間崇, 日本透析医学会学術委員会透析排水管理ワーキンググループ. 透析排水管理に必要な除害施設の導入東京都23区内を例として. 日本臨床工学技士会会誌. 2021. 73. 12-14
峰島三千男, 友雅司, 中元秀友, 宍戸寛治, 秋澤忠男, 内野順司, 本間崇, 日本透析医学会学術委員会透析排水管理ワーキンググループ. 透析排水管理に必要な除害施設の導入東京都23区内を例として. 日本透析医学会雑誌. 2021. 54. 3. 119-122
Tadao Akizawa, Manabu Iwasaki, Yusuke Yamaguchi, Yoshikatsu Majikawa, Michael Reusch. Authors' reply. Journal of the American Society of Nephrology. 2020. 31. 11. 2738-2740
Hiroyasu Yamamoto, Megumi Taguchi, Kiyoshi Nobori, Yoshimi Matsuda, Kazuma Iekushi, Tadao Akizawa. TO INVESTIGATE THE EFFICACY AND SAFETY OF MOLIDUSTAT IN NON-DIALYSIS PATIENTS WITH RENAL ANEMIA WHO ARE NOT TREATED WITH ERYTHROPOIESIS-STIMULATING AGENTS: MIYABI ND-C. NEPHROLOGY DIALYSIS TRANSPLANTATION. 2020. 35. 2177-2177
Tadao Akizawa, Kazuaki Ikejiri, Yuichiro Kondo, Yuichi Endo, Masafumi Fukagawa. Evocalcet: A New Oral Calcimimetic for Dialysis Patients With Secondary Hyperparathyroidism. Therapeutic Apheresis and Dialysis. 2020. 24. 3. 248-257

ｍore...

Books (10)：

服薬指導 Q and A 腎臓病編
医薬ジャーナル社 2003
急性血液浄化療法マニュアル
南江堂 2002
透析療法ネクストII
医学図書出版 2002
透析患者の検査値の読み方
日本メディカルセンター 2002
透析療法のリスクマネジメント
中外医学社 2002

ｍore...

Professional career (1)：

(BLANK)

Committee career (2)：

日本透析医会会長
国際アフェレシス学会理事

Association Membership(s) (7)：

国際血液浄化学会 , 日本透析医学会 , 日本急性血液浄化学会 , 日本人工臓器学会 , 日本腎臓学会 , 国際アフェレシス学会 , 日本アフェレシス学会

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page